Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

80.24 +0.70 (+0.88%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,153,110
Open 79.56
Bid (Size) 78.23 (2)
Ask (Size) 80.18 (1)
Prev. Close 79.54
Today's Range 78.59 - 80.83
52wk Range 62.34 - 142.00
Shares Outstanding 390,600,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-34.81%
-34.81%
1 Month
+3.10%
+3.10%
3 Month
+16.87%
+16.87%
6 Month
-27.26%
-27.26%
1 Year
-35.05%
-35.05%

More News

Read More
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Via The Motley Fool
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
From DexCom, Inc.
Via Business Wire
Peering Into DexCom's Recent Short Interest
Via Benzinga
Key Takeaways From DexCom Analyst Ratings
Via Benzinga
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
Via The Motley Fool
Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout.
Via Chartmill
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
2 Excellent Healthcare Stocks to Hold Through the Next Decade
Via The Motley Fool
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
Via The Motley Fool
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
Via The Motley Fool
Dexcom and ŌURA Announce Strategic Partnership
From DexCom, Inc.
Via Business Wire
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
Via Chartmill
Large-Cap Stocks In Trouble - Sunday, Nov. 17
Via Talk Markets
Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom
Via Benzinga
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
From DexCom, Inc.
Via Business Wire
Analyst Expectations For DexCom's Future
Via Benzinga
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Via Benzinga
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Via Investor's Business Daily
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
Via The Motley Fool
Why DexCom Stock Flopped on Friday
Via The Motley Fool
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
Via Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
Via Investor's Business Daily
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.